Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Rash erythematous, Skin warm, Swelling
Clinical narrative: Swollen, red, painful deltoid; Swollen, red, painful deltoid; Swollen, red, painful deltoid; Skin painful to the touch, and warm; Skin painful to the touch, and warm; Skin painful to the touch, and warm; swollen red rash moved to bicep; Fever >103ºF/ 100ºF fever; Headaches; chills; Other vaccine same date vaccine date 19Nov2021; Dose number: 3; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 30 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 19Nov2021 12:15 (Lot number: FH8030) at the age of 30 years as dose 3 (booster), single for covid-19 immunisation; pneumococcal vaccine polysacch 23v (PNEUMOVAX 23), administered in arm right, administration date 19Nov2021 12:15 PM as (Batch/Lot number: unknown) at Pharmacy or Drug Store. Relevant medical history included: "Tree Nuts Allergy" (unspecified if ongoing), notes: Tree Nuts; "Asthma" (unspecified if ongoing); "Hemiplegic Migraines" (unspecified if ongoing); "Gangrene lymph node removal with appendectomy" (unspecified if ongoing), notes: Gangrene lymph node removal with appendectomy; "Gangrene lymph node removal with appendectomy", start date: 2004 (unspecified if ongoing). Concomitant medication(s) included: BREO ELLIPTA; SINGULAIR. Past drug history included: Amoxicillin, reaction(s): "Amoxicillin: Drug Allergy"; Cefaclor, reaction(s): "Cefaclor: Drug Allergy". Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EN6206, Location of injection: Arm Right, Vaccine Administration Time: 03:00 PM), administration date: 06Mar2021, when the patient was 30 years old, for Covid-19 immunization; Bnt162b2 (Dose Number: 2, Batch/Lot No: EP6955, Location of injection: Arm Right, Vaccine Administration Time: 03:00 PM), administration date: 27Mar2021, when the patient was 30 years old, for Covid-19 immunization. The following information was reported: SWELLING (non-serious), ERYTHEMA (non-serious), PAIN (non-serious) all with onset 19Nov2021 21:00, outcome "recovering" and all described as "Swollen, red, painful deltoid"; PAIN OF SKIN (non-serious), HYPERAESTHESIA (non-serious), SKIN WARM (non-serious) all with onset 19Nov2021 21:00, outcome "recovering" and all described as "Skin painful to the touch, and warm"; RASH ERYTHEMATOUS (non-serious) with onset 19Nov2021 21:00, outcome "recovering", described as "swollen red rash moved to bicep"; PYREXIA (non-serious) with onset 19Nov2021 21:00, outcome "recovering", described as "Fever >103 degree F/ 100 degree F fever"; HEADACHE (non-serious) with onset 19Nov2021 21:00, outcome "recovering", described as "Headaches"; CHILLS (non-serious) with onset 19Nov2021 21:00, outcome "recovering", described as "chills"; PRODUCT USE ISSUE (non-serious) with onset 19Nov2021 21:00, outcome "recovering", described as "Other vaccine same date vaccine date 19Nov2021"; IMMUNISATION (non-serious) with onset 19Nov2021, outcome "unknown", described as "Dose number: 3". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of swelling, erythema, pain, pain of skin, hyperaesthesia, skin warm, rash erythematous, pyrexia, headache, chills, product use issue.  Additional information: It was reported that patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient was not diagnosed with COVID-19. Since the vaccination, the patient have not been tested for COVID-19.  Follow-up attempts are completed. No further information is expected.